Mkts

Ocugen, Inc.

NASDAQ: OCGN
$0.77+0.04 (+4.79%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
0.710.82
52-week range
0.692.73
Today
Open0.71
Previous close0.77
Volume—
Valuation
Market cap262.66M
P/E ratio—
EPS (TTM)-0.20
Income & risk
Dividend / yield—
Beta1.96
Avg volume6.39M
Discussion

OCGN News

Stories mentioning OCGN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,533(193.00)1,7521,3731,481764.001,1361,141
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development11,25510,67011,1498,4029,5298,2908,1088,902
Sales General & Admin
Total Operating Expenses19,37216,80219,37715,16815,98214,60414,38816,590
Operating Income (Loss)(17,839)(16,995)(17,625)(13,795)(14,501)(13,840)(13,252)(15,449)
Interest Income132.00172.00207.00200.00343.00441.00310.00200.00
Interest Expense
Other Expense(150.00)(1,319)65.001.00
Pretax Income
Tax Provision
Net Income (Loss)(19,177)(17,706)(20,051)(14,739)(15,350)(13,880)(12,970)(15,280)
Earnings Per Share (Basic)(0.06)(0.05)(0.04)
Earnings Per Share (Diluted)(0.06)(0.05)(0.04)
Weighted Average Shares Outstanding (Basic)327,544291,997257,354
Weighted Average Shares Outstanding (Diluted)327,544291,997257,354

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About OCGN

Ocugen, Inc. (NASDAQ: OCGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol OCGN. It last traded at $0.7700 (Nov 20, 2026, 4:00 PM ET), up 4.8% on the day. That gives Ocugen a market capitalisation of $262.7M.

Over the past 52 weeks OCGN has traded between $0.6900 and $2.73.

Revenue for the quarter ended Mar 31, 2026 was $1.5M; a net loss of $19.2M. Revenue was up 3.5% from $1.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.5M-$19.2M-1250.9%
Dec 31, 2025-$193.0K-$17.7M—
Sep 30, 2025$1.8M-$20.1M-1144.5%
Jun 30, 2025$1.4M-$14.7M-1073.5%

From Ocugen’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…